{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:47:09Z","timestamp":1793314029380,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"15-16","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.vaccine.2003.11.016","type":"journal-article","created":{"date-parts":[[2004,5,4]],"date-time":"2004-05-04T12:29:33Z","timestamp":1083673773000},"page":"1914-1920","source":"Crossref","is-referenced-by-count":43,"title":["Associations between human leukocyte antigen (HLA) alleles and very high levels of measles antibody following vaccination"],"prefix":"10.1016","volume":"22","author":[{"given":"Inna G","family":"Ovsyannikova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A","family":"Vierkant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Shane Pankratz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A","family":"Poland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2003.11.016_BIB1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00221337","article-title":"Measles, killer of millions in developing countries: strategy for rapid elimination and continuing control","volume":"7","author":"Sabin","year":"1991","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.vaccine.2003.11.016_BIB2","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/S0264-410X(99)00309-6","article-title":"Measles elimination: progress and challenges","volume":"17","author":"Cutts","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.11.016_BIB3","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1001\/archinte.154.16.1815","article-title":"Failure to reach the goal of measles elimination. Apparent paradox of measles infections in immunized persons","volume":"154","author":"Poland","year":"1994","journal-title":"Arch. Int. Med."},{"key":"10.1016\/j.vaccine.2003.11.016_BIB4","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1001\/jama.277.14.1156","article-title":"Measles re-immunization in children seronegative after initial immunization","volume":"277","author":"Poland","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2003.11.016_BIB5","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/00008480-199804000-00017","article-title":"The genetic basis for variation in antibody response to vaccines","volume":"10","author":"Poland","year":"1998","journal-title":"Curr. Opin. Pediatr."},{"key":"10.1016\/j.vaccine.2003.11.016_BIB6","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1016\/S0264-410X(00)00468-0","article-title":"Twin studies of immunogenicity\u2014determining the genetic contribution to vaccine failure","volume":"19","author":"Tan","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.11.016_BIB7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1086\/301736","article-title":"Variability in immune response to pathogens: using measles vaccine to probe immunogenetic determinants of response","volume":"62","author":"Poland","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.vaccine.2003.11.016_BIB8","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev.immunol.17.1.369","article-title":"Structural basis of T cell recognition","volume":"17","author":"Garcia","year":"1999","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.vaccine.2003.11.016_BIB9","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1749-6632.1995.tb44444.x","article-title":"The biochemistry and cell biology of antigen presentation by MHC class I and class II molecules. Implications for development of combination vaccines","volume":"754","author":"Germain","year":"1995","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.vaccine.2003.11.016_BIB10","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1016\/S0264-410X(00)00505-3","article-title":"The role of mass spectrometry in vaccine development","volume":"19","author":"Poland","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.11.016_BIB11","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1086\/315871","article-title":"Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccines of defined HLA genotypes","volume":"182","author":"Nardin","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.11.016_BIB12","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.4049\/jimmunol.162.2.1156","article-title":"Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C","volume":"162","author":"Chang","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.vaccine.2003.11.016_BIB13","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/S0264-410X(98)00429-0","article-title":"Immunogenetic mechanisms of antibody response to measles vaccine: the role of the HLA genes","volume":"17","author":"Poland","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.11.016_BIB14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0198-8859(02)00741-3","article-title":"The association of class I HLA alleles and antibody levels following a single dose of measles vaccine","volume":"64","author":"Jacobson","year":"2003","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.vaccine.2003.11.016_BIB15","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0264-410X(01)00346-2","article-title":"Identification of an association between HLA class II alleles and low antibody levels after measles immunization","volume":"20","author":"Poland","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.11.016_BIB16","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1086\/340573","article-title":"Associations between human leukocyte antigen homozygosity and antibody levels to measles vaccine","volume":"185","author":"St. Sauver","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.11.016_BIB17","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1046\/j.1523-1755.1998.00909.x","article-title":"Distinct HLA class II alleles determine antibody response to vaccination with hepatitis B surface antigen","volume":"53","author":"Caillat-Zucman","year":"1998","journal-title":"Kidney Int."},{"key":"10.1016\/j.vaccine.2003.11.016_BIB18","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/sj.gene.6363792","article-title":"Family study of non-responsiveness to hepatitis B vaccine confirms the importance of HLA class III C4A locus","volume":"2","author":"De Silvestri","year":"2001","journal-title":"Genes Immun."},{"key":"10.1016\/j.vaccine.2003.11.016_BIB19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1201-9712(98)90116-3","article-title":"The relationship of HLA-DQA1 alleles and humoral antibody following measles vaccination","volume":"2","author":"Hayney","year":"1998","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.11.016_BIB20","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0092-8674(83)90170-8","article-title":"A recovered avian myelocytomatosis virus that induces lymphomas in chickens: pathogenic properties and their molecular basis","volume":"35","author":"Enrietto","year":"1983","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2003.11.016_BIB21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1399-0039.1992.tb01940.x","article-title":"HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2h: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation","volume":"39","author":"Olerup","year":"1992","journal-title":"Tiss. Antigens"},{"key":"10.1016\/j.vaccine.2003.11.016_BIB22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1399-0039.1993.tb01991.x","article-title":"HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2h","volume":"41","author":"Olerup","year":"1993","journal-title":"Tiss. Antigens"},{"key":"10.1016\/j.vaccine.2003.11.016_BIB23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1399-0039.1996.tb02623.x","article-title":"HLA-DPA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) and distribution of DPA1 alleles in Caucasian, African and Oriental populations","volume":"48","author":"Aldener-Cannav\u00e1","year":"1996","journal-title":"Tiss. Antigens"},{"key":"10.1016\/j.vaccine.2003.11.016_BIB24","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1128\/JCM.17.5.814-818.1983","article-title":"Enzyme-linked immunosorbent assay for detection of measles antibody","volume":"17","author":"Boteler","year":"1983","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.vaccine.2003.11.016_BIB25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1084\/jem.169.1.59","article-title":"Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets","volume":"169","author":"Heinzel","year":"1989","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.vaccine.2003.11.016_BIB26","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1084\/jem.181.4.1569","article-title":"Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo","volume":"181","author":"Pfeiffer","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.vaccine.2003.11.016_BIB27","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1084\/jem.182.5.1591","article-title":"Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells","volume":"182","author":"Constant","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.vaccine.2003.11.016_BIB28","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1056\/NEJM198909143211103","article-title":"Genetic prediction of nonresponse to hepatitis B vaccine","volume":"321","author":"Alper","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vaccine.2003.11.016_BIB29","first-page":"284","article-title":"Evidence of HLA class II association with antibody response against the malaria vaccine SPF66 in a naturally exposed population","volume":"53","author":"Beck","year":"1995","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.vaccine.2003.11.016_BIB30","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1086\/338014","article-title":"Associations between human leukocyte antigens and nonresponsiveness to influenza vaccine","volume":"185","author":"Gelder","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.11.016_BIB31","doi-asserted-by":"crossref","first-page":"356","DOI":"10.7326\/0003-4819-105-3-356","article-title":"Nonresponsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic tyings","volume":"105","author":"Craven","year":"1986","journal-title":"Ann. Int. Med."},{"key":"10.1016\/j.vaccine.2003.11.016_BIB32","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1006\/clim.2000.4933","article-title":"Humoral response to recombinant hepatitis B virus vaccine at birth: role of HLA and beyond","volume":"97","author":"Martinetti","year":"2000","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.vaccine.2003.11.016_BIB33","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/infdis\/171.6.1387","article-title":"Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum","volume":"171","author":"Robbins","year":"1995","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.11.016_BIB34","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/infdis\/172.6.1591","article-title":"Cellular immunity in measles vaccine failure: demonstration of measles antigen-specific lymphoproliferative responses despite limited serum antibody production after revaccination","volume":"172","author":"Ward","year":"1995","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.11.016_BIB35","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1086\/323346","article-title":"Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months","volume":"184","author":"Gans","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.11.016_BIB36","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1172\/JCI3290","article-title":"Ex vivo analysis of cytotoxic T lymphocytes to measles antigens during infection and after vaccination in Gambian children","volume":"102","author":"Jaye","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vaccine.2003.11.016_BIB37","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0198-8859(01)00376-7","article-title":"Frequency of HLA-DPB1 disparities detected by reference strand-mediated conformation analysis in HLA-A, -B, and -DRB1 matched siblings","volume":"63","author":"B\u00fcchler","year":"2002","journal-title":"Hum. Immunol."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03008089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03008089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T15:23:18Z","timestamp":1682695398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X03008089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":37,"journal-issue":{"issue":"15-16","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0264410X03008089"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2003.11.016","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}